200 Summit Lake Drive
100 articles with FUJIFILM
Biotech and pharma companies came roaring out of the gate on the first day of the annual J.P. Morgan Healthcare Conference with big deals, expansions and promises of growth and pipeline sustainability.
Increasing its biopharmaceutical production capacity and capabilities to meet the growing needs of its customer portfolio
Accelerating the growth of the cell culture media business
Company debuts SonoSite Synchronicity, a new robust workflow solution
New, improved educational website realized with global member feedback
FUJIFILM SonoSite, Inc. today announced its entry into the medical informatics space with the launch of a robust point-of-care workflow solution, SonoSite Synchronicity™.
Company announces a strategic investment by FUJIFILM Corporation to advance pipeline of novel treatments for inflammatory-mediated diseases
FUJIFILM SonoSite Inc. announced the launch of two new transducers for the SonoSite iViz point-of-care ultrasound
FUJIFILM SonoSite Inc., Innovator Of Point-Of-Care Ultrasound, Celebrates 20 Years Of Improving Patient Outcomes
From battlefield to bedside, these rugged and reliable solutions have ushered in a new era of helping clinicians bring ultrasound to any patient, anywhere, anytime.
FUJIFILM Cellular Dynamics Announces Agreement With University Of California - Irvine To Commercialize iPSC-derived Microglia And Media Formulation
FUJIFILM Cellular Dynamics, Inc., licenses University of California - Irvine's technologies for derivation of microglia
Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media
FUJIFILM Corporation announced that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD. (ISJ).
JXTG Nippon Oil & Energy Corporation has announced it has agreed to sell Irvine Scientific Sales Company, Inc. and IS Japan Co., Ltd. to FUJIFILM Corporation (FujiFilm).
Fujifilm Announces the Opening of its Flexible Manufacturing Facility for the Production of Clinical And Commercial Gene Therapies
FUJIFILM and Advanced Therapies, has announced the opening of its state-of-the art Flexible Manufacturing Facility in College Station, Texas.
FUJIFILM signed an agreement on December 19th for the investment of 470 million yen in EdiGene, a drug discovery startup, participating its series A round.
"Fujifilm SonoSite is here to help our customers increase workflow efficiencies to deliver better care and improved patient outcomes with our leading point-of-care ultrasound technologies."
Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business, Increasing Monoclonal Antibody Capacity for Process Development and GMP Production at U.S.A. and U.K. Sites
FUJIFILM Corporation is to invest a total of 3.2 billion yen on its CDMO*1 sites in the U.S.A. and the U.K. in order to accelerate the expansion of the company's business for developing and manufacturing biopharmaceuticals under contract for other parties.
FUJIFILM Release: Clinical Trials Of Anti-cancer Agent FF-10832 To Start In The U.S. For Advanced Solid Tumors